Clinical Study
The Effects of Antimicrobial Peptide Nal-P-113 on Inhibiting Periodontal Pathogens and Improving Periodontal Status
Table 1
Baseline demographic and clinical characteristics.
| Group | Number | Age/years | Sex | PD | CAL | BI | (mean ± SD) | (mean ± SD) | (mean ± SD) | (mean ± SD) | male | female | experimental | control | experimental | control | experimental | control |
| Split-mouth clinical trial | 37 | 35.78 ± 10.70 | 19 | 18 | 5.45 ± 1.58 | 5.58 ± 1.50 | 3.12 ± 1.29 | 3.15 ± 1.25 | 3.00 ± 0.75 | 2.97 ± 0.76 | | | | | | 0.33 | 0.71 | 0.41 |
|
|